2,6-Lutidine → N-(5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenyl)-4-methyl-3-(4-pyridin-3-yl-[1,2,3]triazol-1-yl)-benzamide
Reaction equation
[CH3:1][C:2]1[CH:10]=[CH:9][C:5]([C:6]([OH:8])=O)=[CH:4][C:3]=1[N:11]1[CH:15]=[C:14]([C:16]2[CH:17]=[N:18][CH:19]=[CH:20][CH:21]=2)[N:13]=[N:12]1.C(Cl)(=O)C(Cl)=O.[NH2:28][C:29]1[C:30]([O:44][CH3:45])=[C:31]([NH:39][S:40]([CH3:43])(=[O:42])=[O:41])[CH:32]=[C:33]([C:35]([CH3:38])([CH3:37])[CH3:36])[CH:34]=1.N1C(C)=CC=CC=1C>C(Cl)Cl.CN(C=O)C.C1COCC1>[C:35]([C:33]1[CH:32]=[C:31]([NH:39][S:40]([CH3:43])(=[O:42])=[O:41])[C:30]([O:44][CH3:45])=[C:29]([NH:28][C:6](=[O:8])[C:5]2[CH:9]=[CH:10][C:2]([CH3:1])=[C:3]([N:11]3[CH:15]=[C:14]([C:16]4[CH:17]=[N:18][CH:19]=[CH:20][CH:21]=4)[N:13]=[N:12]3)[CH:4]=2)[CH:34]=1)([CH3:38])([CH3:36])[CH3:37]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
4-Methyl-3-(4-pyridin-3-yl-1,2,3-triazol-1-yl)-benzoic acid (76.3 mg; 0.272 mmol) was suspended in 5 mL of CH2Cl2, and 1 mL of THF, and 0.04 mL (0.4 mmol) of oxalyl chloride was added. One drop of DMF was then added to the stirring suspension, and the mixture was stirred for 2 h. The resulting cloudy solution was concentrated to dryness and suspended in CH2Cl2. N-(3-Amino-5-tert-butyl-2-methoxy-phenyl)-methane-sulfonamide (81 mg; 0.30 mmol) was added, then 0.06 mL (0.5 mmol) of 2,6-lutidine, and the resulting solution was stirred overnight. The mixture was then washed with 1M NaHSO4, saturated NaHCO3, and brine. The organic portion was dried with Na2SO4, filtered, and concentrated. Chromatography (0–6.5% MeOH in CH2Cl2), with careful selection of only the pure fractions, provided 80 mg (0.15 mmol; 55%) of Example 14. ESI MS m/z 535 [C27H30N6O4S+H]+.
Workup
- concentrationThe resulting cloudy solution was concentrated to dryness
- washThe mixture was then washed with 1M NaHSO4, saturated NaHCO3, and brine
- dry with materialThe organic portion was dried with Na2SO4
- filtrationfiltered
- concentrationconcentrated
- customChromatography (0–6.5% MeOH in CH2Cl2), with careful selection of only the pure fractions, provided 80 mg (0.15 mmol; 55%) of Example 14
Sources & evidence
- ORD record
- ord-7c86a327818c49cb87ede7569407aa9b
- Source dataset
- uspto-grants-2007_05
- Patent number
- US07214802B2
Reaction notes
Loading…